Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.

The following is a summary of “Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today ann ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.

The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.

The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

Use these natural, kitchen cabinet cures to get rid of painful corns and calluses. The post 8 Reliable Home Remedies for ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

The new PDUFA target date is March 12, 2025. The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the ...

The following home remedies that may offer some relief ... Opzelura was the first JAK inhibitor approved for atopic dermatitis treatment in the United States, making it the first treatment of its kind ...